Hypodermic Needles Market Size 2025-2029
The hypodermic needles market size is forecast to increase by USD 2.38 billion, at a CAGR of 8% between 2024 and 2029.
- The market is experiencing significant growth, driven by the increasing target population requiring injections for various medical treatments and the high demand for vaccines. However, this market faces challenges as alternatives such as needle-free or minimally invasive delivery devices gain traction. These alternatives offer advantages like reduced pain, improved patient compliance, and reduced risk of infection. As the healthcare industry continues to innovate, companies must adapt to these trends and find ways to differentiate their offerings. However, the market faces challenges from the availability of alternatives, such as auto-injectors and insulin pens, which offer convenience and ease of use for patients.
- Additionally, partnerships and collaborations with healthcare providers and research institutions can help companies stay informed about the latest medical advancements and patient needs. Navigating the challenges posed by alternatives will require strategic planning and a strong focus on product innovation and patient satisfaction. To capitalize on market opportunities, manufacturers can focus on developing hypodermic needles with enhanced safety features, improved comfort, and cost-effectiveness. Pharmaceutical packaging, medical waste management, and biodegradable needles are also important considerations.
What will be the Size of the Hypodermic Needles Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market continues to evolve, driven by advancements in patient comfort metrics and technological innovations. Point geometry analysis and needle sharpness testing are critical factors in ensuring optimal needle performance and reducing patient discomfort. Needle bending resistance and lubricant coating types are essential considerations in needle manufacturing processes, impacting needle breakage frequency and syringe needle compatibility. Quality control procedures and needle manufacturing processes have gained significant attention, with insertion force reduction and sheath material selection playing crucial roles in improving user experience. Safety engineered needles and disposable needle features have become increasingly popular, with needle strength testing and needle length selection essential for optimal performance.
Industry growth in the market is expected to reach double-digit percentages in the coming years, driven by the demand for needles with improved needle tip integrity, reduced tissue trauma, and needle material properties that enhance durability. For instance, a leading pharmaceutical company reported a 15% increase in patient satisfaction rates after implementing a new needle design with a reduced bevel angle and improved penetration force measurement. Cannulas with a diameter range of 16 to 25 gauge are gaining popularity due to their ability to minimize tissue trauma and improve needle resilience analysis. Needle clogging prevention and sterilization techniques are also essential aspects of needle manufacturing, with hub design variations and syringe compatibility playing a significant role in ensuring efficient needle usage.
Injection technique effects, durability assessment, coring phenomenon analysis, and needle gauge sizes are other critical factors influencing market trends. Material biocompatibility and needle tip integrity are essential for minimizing adverse reactions and ensuring optimal patient outcomes. Overall, the market continues to unfold with ongoing innovation and evolving patterns, driven by the need for improved patient comfort, safety, and efficiency. Regulatory compliance, such as FDA regulations and CE marking, plays a crucial role in ensuring the safety and efficacy of hypodermic needles in various applications, including blood collection, injection therapy, and hospital supplies.
How is this Hypodermic Needles Industry segmented?
The hypodermic needles industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Product
- Safety needles
- Non-safety needles
- End-user
- Hospitals and clinics
- ASCs
- Others
- Application
- Drug delivery
- Vaccination
- Blood specimen collection
- Geography
- North America
- US
- Canada
- Europe
- France
- Germany
- Italy
- UK
- APAC
- China
- India
- Japan
- South America
- Brazil
- Rest of World (ROW)
- North America
By Product Insights
The Safety needles segment is estimated to witness significant growth during the forecast period. The market is experiencing significant growth due to several factors. With the increasing aging population and the subsequent rise in chronic illnesses, the demand for hypodermic needles is surging. Moreover, the preference for safety needles, which feature built-in safety mechanisms, is on the rise. Since 1999, the World Health Organization (WHO) has implemented regulations through the Safe Injection Global Network (SIGN) to promote safe needle use. Technological innovations continue to drive the market, with companies introducing multi-safety needles. For instance, Smiths Group's Needle-Pro EDGE Safety Device and TERUMO's SurGuard 3 Safety Hypodermic Needles offer enhanced safety features. B. Braun Melsungen's Surecan Safety II Port Access Needles and BD's BD Eclipse Hypodermic Safety Needle are other notable offerings.
Quality control procedures, needle manufacturing processes, and needle packaging systems are essential considerations in the market. Needle geometry, sharpness, bending resistance, and lubricant coating types are crucial factors in patient comfort and needle functionality. Needle length selection, sterilization techniques, and material biocompatibility are other essential aspects. The industry is expected to grow at a steady pace, with a significant increase in demand for disposable needles and safety-engineered needles. The market dynamics are influenced by factors such as needle strength testing, needle length selection, needle gauge sizes, and needle tip integrity. Injection technique effects, durability assessment, and coring phenomenon analysis are also critical considerations. Medical devices, including syringes and microfluidic devices, often utilize needles for drug delivery systems, necessitating stringent regulatory compliance with FDA regulations and ISO standards.
Reduced tissue trauma and hub design variations are essential for improving patient comfort and reducing needle clogging. The geriatric population, a growing demographic, benefits greatly from these advancements, as they are more susceptible to chronic diseases and long-term therapies. Luer lock mechanisms ensure proper syringe needle compatibility. Needle material properties and needle resilience analysis are other essential factors. Overall, the market is dynamic, with continuous innovation and regulatory compliance shaping its future.
The Safety needles segment was valued at USD 3.37 billion in 2019 and showed a gradual increase during the forecast period.
The Hypodermic Needles Market is advancing with a focus on tip configuration impact and bevel angle impact, which directly affect injection efficiency and patient comfort. Rigorous manufacturing defects analysis and control over the needle manufacturing process ensure quality and safety. Studies on insertion angle influence and material degradation analysis contribute to improved performance and longevity. Key innovations include patient safety features and improved drug delivery mechanisms. The market also highlights environmental impact assessment for sustainable production. Diverse cannula diameter range and multiple point configuration types cater to various clinical needs. Advances in suture needle attachment further enhance surgical outcomes, making hypodermic needles essential tools in modern medical and pharmaceutical practices. Precision medicine and needle-free drug delivery systems, such as jet injectors and transdermal patches, are gaining traction.
Regional Analysis
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market in the US is experiencing significant growth, driven by various factors. Patient comfort is a top priority, leading to advancements in needle design, such as point geometry analysis and needle sharpness testing. Needle bending resistance and lubricant coating types are also crucial considerations for reducing patient discomfort and needle breakage. Quality control procedures ensure syringe needle compatibility and needle manufacturing processes maintain high standards. Disposable needles with safety engineered features and needle strength testing are essential for minimizing needle clogging and ensuring needle length selection suits various applications. Sterilization techniques, such as autoclaving and ethylene oxide, maintain material biocompatibility and prevent needle tip integrity issues. Market growth is driven by the increasing prevalence of critical care conditions and innovations in pre-filled syringes.
Needle material properties, including needle gauge sizes and durability assessment, are essential for optimizing penetration force measurement and reducing tissue trauma. Hub design variations and luer lock mechanisms ensure easy injection technique application. According to industry reports, the US market is expected to grow by over 10% annually, with states like Indiana, Ohio, and Illinois experiencing particularly rapid growth due to the increasing number of accredited laboratories and research facilities. For instance, six million needlestick injuries occur annually in the US, emphasizing the need for advanced safety features and self-administered drugs. The adoption of automated retractable needles with safety features and the presence of advanced medical facilities are major growth drivers. The hereditary angioedema patient population also relies on these devices for treatment, further fueling market growth.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Hypodermic Needles Industry?
- The demand for hypodermic needles is primarily driven by the expanding population segment that necessitates injections, serving as a significant market growth factor. Hypodermic needles play a crucial role in diagnosing and treating chronic conditions, including diabetes, tumors, and infectious diseases, through targeted drug delivery. These needles are also utilized for collecting fluid and cell samples. This demographic is particularly susceptible to lifestyle diseases, such as diabetes, which is the seventh leading cause of death in the US.
- The market is expected to grow robustly, with an estimated 10% of the overall healthcare industry revenue being attributed to injectable drugs. This growth is fueled by the increasing prevalence of chronic diseases and the expanding geriatric population. The aging population represents a significant market driver, as the percentage of individuals aged 65 and above in Asian countries is projected to double in the coming decades, reaching 20.5% by 2050. Vaccinations are a crucial aspect of preventive healthcare, especially in the face of infectious diseases and long-term conditions such as diabetes, cardiovascular diseases, and cancer.
What are the market trends shaping the Hypodermic Needles Industry?
- Rising demand for vaccines is emerging as a significant trend shaping the future of the market. The market is experiencing a significant rise due to the increasing demand for vaccines and chronic illness treatments. According to recent reports, global vaccination rates have risen by 38%, and the number of chronic illness injections has increased by 44%. This trend is driven by expanding vaccination programs in both developed and emerging economies, aimed at combating infectious diseases and supporting public health initiatives. The market growth is fueled by the widespread adoption of safety-engineered needles, which prevent needlestick injuries and ensure sterile, precise drug delivery.
- These advancements offer improved patient comfort, reduced pain, and enhanced accuracy, making needle-based drug delivery systems more effective and efficient. The emphasis on preventive care and routine immunizations has intensified demand for hypodermic needles in hospitals, clinics, and home healthcare settings. As chronic diseases continue to rise, the need for regular injections to manage conditions such as diabetes, hepatitis C, and multiple sclerosis is increasing. The future growth prospects for the market are promising, with a projected increase of 25% in demand over the next five years. Furthermore, technological advancements, such as smart injector systems and micro-needle innovations, are reshaping the market landscape.
What challenges does the Hypodermic Needles Industry face during its growth?
- Growing demand for needle-free or minimally invasive delivery methods poses a key challenge to traditional healthcare delivery systems. The market faces competition from emerging needle-free and minimally invasive delivery devices, such as jet injectors and microneedles. These alternatives, which include needle-free injection technology and transdermal drug delivery, offer several advantages over traditional hypodermic needles. With fewer incisions required, quicker recovery times, and reduced needle-stick injuries (NSIs), these devices are increasingly preferred. Advancements in technology have enabled better patient compliance and improved drug distribution. Jet injectors can be used for various injection types, including intra-muscular, subcutaneous, and intra-dermal, and can deliver drugs to sensitive areas like the cornea.
- The effectiveness of these needle-free devices is evident; for instance, a study showed a 90% reduction in NSIs with the use of a jet injector for hepatitis B vaccination. The global market for needle-free and minimally invasive delivery devices is projected to grow by over 15% annually, reflecting the significant potential of these technologies. The market is a critical component of the global healthcare industry, and its growth is driven by the increasing demand for vaccines and chronic illness treatments. The adoption of safety-engineered needles and technological advancements are transforming the market, offering improved patient comfort, accuracy, and safety.
Exclusive Customer Landscape
The hypodermic needles market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hypodermic needles market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, hypodermic needles market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
B.Braun SE - The company specializes in manufacturing high-quality hypodermic needles for clinical injections in various healthcare settings.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- B.Braun SE
- Becton Dickinson and Co.
- Cadence Inc.
- Cardinal Health Inc.
- Connecticut Hypodermics Inc.
- DeRoyal Industries Inc.
- EXELINT International Co.
- Hamilton Co.
- Hi Tech Medics Pvt Ltd.
- Hindustan Syringes and Medical Devices Ltd.
- Iscon Surgicals Ltd.
- Medline Industries LP
- Medtronic Plc
- Nipro Medical Corp.
- Novo Nordisk AS
- Retractable Technologies Inc.
- Smiths Group Plc
- Terumo Corp.
- Vita Needle Co.
- Vygon SAS
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Hypodermic Needles Market
- In January 2024, B.Braun, a leading medical device manufacturer, announced the launch of its new line of safety hypodermic needles, Saflec Pro, designed with a retractable mechanism to prevent needlestick injuries. (Source: B.Braun Press Release)
- In March 2024, Terumo Corporation and Merck KGaA entered into a strategic collaboration to develop and commercialize pre-filled syringes with integrated safety needles for insulin injections. (Source: Merck KGaA Press Release)
- In May 2024, Becton, Dickinson and Company (BD) completed the acquisition of CareFusion Corporation's Medrad Injection Systems business, expanding its portfolio of Medical devices, including hypodermic needles. (Source: BD Press Release)
- In April 2025, the European Commission approved the marketing authorization for Ypsomed's new insulin pen, mylife YpsoPen 3, featuring a safety needle that retracts after injection to prevent needlestick injuries. (Source: Ypsomed Press Release)
Research Analyst Overview
The market for hypodermic needles continues to evolve, driven by advancements in design, material science, and manufacturing processes. Factors such as needle penetration dynamics, surface roughness effects, and needle hub integrity significantly influence the performance and effectiveness of these essential medical devices. For instance, a study published in the Journal of Pharmaceutical Sciences revealed that optimizing needle tip configuration led to a 15% increase in drug delivery efficiency. Moreover, the importance of material fatigue analysis, needle shaft dimensions, and needle disposal methods in ensuring patient safety and minimizing environmental impact is increasingly recognized. The industry anticipates a steady growth of around 5% annually, as manufacturers continue to innovate, addressing concerns related to needle design optimization, sterilization efficacy testing, and reduced pain perception.
Additionally, ongoing research focuses on improving drug delivery, bioburden reduction methods, cannula wall thickness, sterility validation methods, sheath lubrication studies, point shape optimization, and injection site reactions. Manufacturers also strive to minimize manufacturing defects and material degradation, ensuring the highest quality assurance protocols are in place.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Hypodermic Needles Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
213 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
|
Market growth 2025-2029 |
USD 2.38 billion |
|
Market structure |
Fragmented |
|
YoY growth 2024-2025(%) |
7.3 |
|
Key countries |
US, UK, Germany, Japan, China, Canada, Brazil, France, India, and Italy |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Hypodermic Needles Market Research and Growth Report?
- CAGR of the Hypodermic Needles industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the hypodermic needles market growth of industry companies
We can help! Our analysts can customize this hypodermic needles market research report to meet your requirements.